🤖 AI Summary
Existing multimodal brain network fusion approaches often overlook modality-specific characteristics due to shallow interactions or excessive homogenization, and they statically incorporate expert priors, thereby limiting their predictive performance for attention-related disorders. To address these limitations, this work proposes a Transformer-based framework that introduces an Adaptive Mutual Distillation (AMD) mechanism to enable hierarchical and collaborative interaction between functional and structural connectivity. Additionally, a Selective Prior Fusion (SPF) module is designed to dynamically integrate neuroanatomical knowledge. Experiments on the ABCD dataset demonstrate that the proposed method significantly outperforms current state-of-the-art models, achieving higher accuracy in disorder prediction and overcoming the constraints of conventional multimodal fusion strategies and static prior utilization.
📝 Abstract
Predicting clinical outcomes from brain networks in large-scale neuroimaging cohorts such as the Adolescent Brain Cognitive Development (ABCD) study requires effectively integrating functional connectivity (FC) and structural connectivity (SC) while incorporating expert neurobiological knowledge. However, existing multimodal fusion approaches are shallow or over-homogenize the inherently heterogeneous characteristics of FC and SC, while expert-defined anatomical priors are underutilized with static integration. To address these limitations, we propose Brain Transformer with Adaptive Mutual-Distill and Selective Prior Fusion (BrainTAP). We introduce Adaptive Mutual Distill (AMD), which enables layer-wise information exchange between modalities through learnable distill-intact ratios, preserving modality-specific signals while capturing cross-modal synergies. We further develop Selective Prior Fusion (SPF), which integrates expert-defined anatomical priors in an adaptive way. Evaluated on the ABCD dataset for predicting attention-related disorders, BrainTAP achieves superior performance over state-of-the-art baselines, demonstrating its effectiveness for brain disorder prediction.